Legal Representation
Attorney
M. Sue Michael
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 15, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 15, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 11, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 19, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 30, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jul 16, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 10, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 3, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 3, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 3, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 17, 2008 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Jan 16, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 30, 2007 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Nov 29, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 29, 2007 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| May 25, 2007 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 17, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 16, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 16, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 11, 2006 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Dec 11, 2006 | CEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED | Loading... |
| Dec 3, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 19, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biologic therapeutics and products, namely, growth factors in the nature of chondroinductive, osteoinductive and angiogenic substances; bone, dermal and orthopedic soft tissue extracts for use as implant material; bone, cardiac, dermal and orthopedic soft tissue grafts; surgical implants comprised of living tissue, namely, bone, cardiac, dermal and orthopedic soft engineered tissues; adhesives for spinal, orthopedic and dental tissue repair, regeneration and augmentation; cells for medical and clinical use; genes for medical use in the nature of nucleic acid sequences that facilitate osseointegration, chondrointegration and the integration of other tissues, grafts and implants during spinal, orthopedic and dental tissue repair, regeneration and augmentation; pharmaceuticals for use in spinal, orthopedic and dental tissue repair, regeneration and augmentation; nutraceuticals for use as a dietary supplement in spinal, orthopedic and dental tissue repair, regeneration and augmentation; natural and/or synthetic polymers for use in spinal, orthopedic and dental tissue repair, regeneration and augmentation; cytokine, namely, substances that promote movement and interaction of cells during spinal, orthopedic and dental tissue repair, regeneration and augmentation; attachment factors, namely, substances that promote attachment of cells during spinal, orthopedic and dental tissue repair, regeneration and augmentation
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005